High-profile gastroenterologists and hepatologists have rejected a Cochrane Review which claims direct acting antivirals do not reduce morbidity or mortality in people with hepatitis C. The Gastroenterological Society of Australia has labelled the review “flawed” and is urging doctors not to stop prescribing DAAs, seen as the key to eliminating hepatitis C in Australia. The ...
Hep C experts reject ‘flawed’ Cochrane review
By Tessa Hoffman
22 Jun 2017